Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lisa Bodei

11PUBLICATIONS

56CO-AUTHORS

Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Feb 02, 2026

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.

Salomon Tendler, Roberto De Gregorio, Paul Balderes

|Nov 24, 2025

Differential Clearance of [<sup>177</sup>Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors.

James Russell, Milan Grkovski, Joseph A O'Donoghue

|Nov 20, 2025

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Rohit Thummalapalli, Salomon Tendler, Joanne F Chou

|May 02, 2025

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi

|May 16, 2024

Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

Anna Koumarianou, Pier Luigi Filosso, Lisa Bodei

|Jun 27, 2022

Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.

Joshua A Korsen, Julia A Gutierrez, Kathryn M Tully

Pageof 2

Frequent Collaborators

4 joint publications

Jason S Lewis

3 joint publications

Charles M Rudin

2 joint publications

George Sgouros

2 joint publications

Jessie R Nedrow

2 joint publications

Lukas M Carter

2 joint publications

Heiko Schöder

2 joint publications

Salomon Tendler

2 joint publications

Michael J Morris

1 joint publications

Ali Pirasteh

1 joint publications

Petra Lovrec

Frequent Collaborators

4 joint publications

Jason S Lewis

3 joint publications

Charles M Rudin

2 joint publications

George Sgouros

2 joint publications

Jessie R Nedrow

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on : Feb 03, 2023

See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a <sup>68</sup>Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on : Feb 03, 2023

See more related videos